Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus

被引:4
作者
Desai, K. N. Pannag [1 ]
Roopakala, M. S. [1 ]
Silvia, C. R. Wilma Delphine [2 ]
Kumar, K. M. Prasanna [3 ]
机构
[1] MS Ramaiah Med Coll, Dept Physiol, Bangalore 560054, Karnataka, India
[2] Sapthagiri Inst Med Sci & Res Ctr, Dept Biochem, Bangalore 560090, Karnataka, India
[3] MS Ramaiah Med Coll, Dept Endocrinol, Bangalore 560054, Karnataka, India
关键词
Fibrinogen; Diabetes mellitus; Glycated hemoglobin; Endothelium; Body Mass Index; ENDOTHELIAL DYSFUNCTION; GLYCEMIC CONTROL;
D O I
10.1007/s13410-012-0093-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to assess the plasma fibrinogen levels in type 2 diabetes mellitus patients and to compare with that of healthy controls. To correlate plasma fibrinogen levels with blood pressure (BP), BMI (Body Mass Index) and HbA1c (Glycated hemoglobin) among diabetics and healthy controls. Blood samples were collected for Plasma fibrinogen levels and HbA1c from 30 diagnosed type 2 diabetes mellitus patients. Their BP and BMI were recorded. 30 age and sex matched healthy subjects were included as a control group. There was a rise in plasma fibrinogen levels in diabetics with BMI < 25 kg/m(2) as compared to controls of the same BMI group (P = 0.097). Also, there was a trend of raised plasma fibrinogen levels among male diabetics as compared to male control subjects (P = 0.079). However, there appears no such difference among female individuals. However, there was no significant correlation between fibrinogen levels, blood pressure and HbA1c both among controls and diabetic cases (P > 0.05). Though there was a slight trend of increasing levels of plasma fibrinogen among diabetics as compared to controls. However, a significant positive correlation between BMI, male gender and increasing age with plasma fibrinogen was found.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 9 条
  • [1] Endothelial dysfunction: Causes and consequences in patients with diabetes mellitus
    Avogaro, Angelo
    de Kreutzenberg, Saula Vigili
    Fadini, GianPaolo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 : S94 - S101
  • [2] Chugh S N, 2010, J Assoc Physicians India, V58, P478
  • [3] Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age
    Ella, Nebal A. Aboul
    Shehab, Dina I.
    Ismail, Mervat A.
    Maksoud, Awatif A.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (03) : 185 - 195
  • [4] Guerci B, 2001, DIABETES METAB, V27, P425
  • [5] Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853
  • [6] Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients
    Langouche, Lies
    Meersseman, Wouter
    Perre, Sarah Vander
    Milants, Ilse
    Wouters, Pieter J.
    Hermans, Greet
    Gjedsted, Jakob
    Hansen, Troels K.
    Amout, Jozef
    Wilmer, Alexander
    Schetz, Miet
    Van den Berghe, Greet
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (05) : 1475 - 1480
  • [7] LE DSNT, 2008, HAEMATOLGIA, V82, P317, DOI DOI 10.1016/J.DIABRES.2008.08.019
  • [8] Panwar RB, 2011, INDIAN J MED RES, V134, P26
  • [9] Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation
    Pieters, Marlien
    van Zyl, Danie G.
    Rheeder, Paul
    Jerling, Johann C.
    Loots, Du Toit
    van der Westhuizen, Francois H.
    Gottsche, Louise T.
    Weisel, John W.
    [J]. THROMBOSIS RESEARCH, 2007, 120 (03) : 439 - 446